T0	Participants 21 59	tongue and floor of the mouth cancers.
T1	Participants 61 144	Since January 1974, 95 patients with anterior tongue and floor of the mouth cancers
T2	Participants 247 294	one-third of the patients received chemotherapy
T3	Participants 417 480	one-third of the patients received immunotherapy with weekly C.
T4	Participants 481 498	parvum injections
T5	Participants 525 540	remaining third
T6	Participants 788 833	Patients who previously received radiotherapy